scholarly article | Q13442814 |
P356 | DOI | 10.1002/AJMG.10515 |
P698 | PubMed publication ID | 12116197 |
P50 | author | Eliecer Coto | Q91531533 |
Ignacio F Mata | Q40102964 | ||
P2093 | author name string | Carmen Martínez | |
Victoria Alvarez | |||
Ignacio F Mata | |||
Pelayo González | |||
Carlos H Lahoz | |||
Joaquín Peña | |||
Luis M Guisasola | |||
P2860 | cites work | Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease. | Q51981238 |
A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. | Q53228560 | ||
Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03. | Q53231515 | ||
TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD. | Q53235705 | ||
Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism | Q58452081 | ||
Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population | Q71547126 | ||
Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology | Q73807424 | ||
Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism | Q73873232 | ||
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 | ||
Inflammation and Alzheimer's disease | Q28138617 | ||
Dual role of tumor necrosis factor alpha in brain injury | Q33879032 | ||
Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. | Q33900383 | ||
The role of TNF and its receptors in Alzheimer's disease | Q34469501 | ||
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation | Q36082965 | ||
Risk of Alzheimer's disease and duration of NSAID use. | Q39457609 | ||
Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. | Q40946540 | ||
A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis | Q40949167 | ||
The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. | Q41117030 | ||
Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative | Q44267597 | ||
Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha | Q47885336 | ||
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria | Q48009520 | ||
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia | Q48121615 | ||
TNF alpha gene expression is induced in neurones after a hippocampal lesion. | Q48187813 | ||
TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS. | Q48778348 | ||
Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study | Q48939488 | ||
P433 | issue | 5 | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 574-577 | |
P577 | publication date | 2002-07-01 | |
P1433 | published in | American Journal of Medical Genetics Part A | Q15755121 |
P1476 | title | Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease. | |
P478 | volume | 114 |
Q53303396 | APOE epsilon-4 allele and cytokine production in Alzheimer's disease. |
Q53361330 | Association between TNF-α promoter -308 A/G polymorphism and Alzheimer's disease: a meta-analysis. |
Q36882004 | Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease |
Q37083159 | Association of tumor necrosis factor-α gene polymorphism (-308) and obstructive sleep apnea-hypopnea syndrome |
Q36718053 | Candidate genes for antidepressant response to selective serotonin reuptake inhibitors |
Q47579780 | Characterisation of amyloid-induced inflammatory responses in the rat retina |
Q33654621 | Commonly studied polymorphisms in inflammatory cytokine genes show only minor effects on mortality and related risk factors in nonagenarians |
Q78344719 | Current awareness in geriatric psychiatry |
Q23910386 | Cytokine polymorphisms and relationship to disease |
Q58549216 | Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review |
Q41850092 | Functional inflammatory genotypes in ischemic stroke: could we use them to predict age of onset and long-term outcome? |
Q41136953 | Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility. |
Q35686013 | Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran |
Q38018496 | Genetic determinants of neuronal vulnerability to apoptosis. |
Q54485999 | Human cytokine response to ex vivo amyloid-beta stimulation is mediated by genetic factors. |
Q36571241 | Lack of Association between Tumor Necrosis Factor-alpha -308 G/A Polymorphism and Risk of Developing Late-Onset Alzheimer's Disease in an Iranian Population. |
Q36600561 | Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease. |
Q37762260 | Perispinal etanercept: a new therapeutic paradigm in neurology |
Q38050498 | Review: systemic inflammation and Alzheimer's disease |
Q37954456 | Systemic and central immunity in Alzheimer's disease: therapeutic implications |
Q53269691 | TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. |
Q38970893 | Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease |
Q58045474 | The ageing immune system and its clinical implications |
Q53304397 | The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease. |
Q54739818 | Tumor necrosis factor-alpha gene promoter polymorphisms in chronic schizophrenia. |
Q22241425 | Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease |
Search more.